New study determines how long Zika remains in body fluids

February 20, 2017 by Melva Robertson
Transmission electron micrograph (TEM) of Zika virus. Credit: Cynthia Goldsmith/Centers for Disease Control and Prevention

A study published in the New England Journal of Medicine provides evidence that the Zika virus particles remain longer in blood than in urine and some other body fluids. This information suggests that blood serum may be the superior diagnostic specimen.

The study was led by researchers from the U.S. Centers for Disease Control and Prevention (CDC), and included multiple partners including researchers at the Rollins School of Public Health at Emory University.

The team sought to determine the frequency and duration of detectable Zika Virus (ZIKV) RNA in blood, urine, semen, and other . It is the first study to examine multiple body fluids for the presence of Zika virus over a length of time. Specimens from more than 150 ZIKV RNA-positive men and women in Puerto Rico were collected within one week of diagnosed Zika symptoms, with regular testing occurring over a six-month period.

According to the results, half of the participants had detectable in at 14 days after the start of symptoms with five percent still detectable at 54 days. In urine specimens, half of the participants had virus particles at eight days, with five percent still detectable at 39 days.

Researchers also examined traceable Zika particles in semen to determine how long men may be able to transmit the virus to partners. Results indicated that Zika remained longer in semen than other body fluids, with half of the participants showing virus particles one month after the start of symptoms and five percent remaining after three months. Regarding women, Zika virus particles that remained in blood serum were largely undetectable in vaginal fluids and saliva specimens of both men and women after one week.

"The findings of this study are important for both diagnostic and prevention purposes," says Eli Rosenberg, PhD, assistant professor in the Department of Epidemiology at Emory's Rollins School of Public Health and scientific co-investigator of the study. "The results fully support current CDC sexual transmission recommendations but also provide critical information to help in understanding how often and how long evidence of Zika virus can be found in different body fluids. This knowledge is key to improving accuracy and effectiveness of testing methods while providing important baseline information for future research."

Explore further: New insight into course and transmission of Zika infection

More information: Gabriela Paz-Bailey et al. Persistence of Zika Virus in Body Fluids—Preliminary Report, New England Journal of Medicine (2017). DOI: 10.1056/NEJMoa1613108

Related Stories

New insight into course and transmission of Zika infection

October 6, 2016
Though first documented 70 years ago, the Zika virus was poorly understood when it burst onto the scene in the Americas in 2015. In one of the first and largest studies of its kind, a research team lead by virologists at ...

NIH funds study of Zika infections in US Olympic athletes

July 5, 2016
Researchers will study some U.S. athletes for Zika during the summer Olympics and Paralympics in Brazil, to better understand how the virus infects.

Researchers obtain first Zika sequence isolated from semen

October 13, 2016
A team of researchers from the United Kingdom has obtained the first complete genome sequence of Zika virus that was isolated from a semen sample. The research is published this week in Genome Announcements, a journal of ...

Italian carries Zika in sperm for record six months

August 12, 2016
An Italian man carried Zika in his sperm for six months after showing the first symptoms of the virus, twice as long as in any previously reported case, according to a new study.

New scientific evidence of sexual transmission of the Zika virus

April 15, 2016
A study by researchers from Inserm, the Paris Public Hospitals (Bichat Hospital, AP-HP), Aix-Marseille University, and the National Reference Centre for Arboviruses confirms that the ZIKA virus can be transmitted sexually. ...

Zika virus: Five things to know

February 8, 2016
A concise "Five things to know about.... Zika virus infection" article for physicians highlights key points about this newly emerged virus in CMAJ (Canadian Medical Association Journal)

Recommended for you

Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017
Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

Snail fever progression linked to nitric oxide production

September 14, 2017
Bilharzia, caused by a parasitic worm found in freshwater called Schistosoma, infects around 200 million people globally and its advance can lead to death, especially in children in developing countries.

Systems analysis points to links between Toxoplasma infection and common brain diseases

September 13, 2017
More than 2 billion people - nearly one out of every three humans on earth, including about 60 million people in the United States - have a lifelong infection with the brain-dwelling parasite Toxoplasma gondii.

Study clears important hurdle toward developing an HIV vaccine

September 13, 2017
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...

As 'flesh-eating' Leishmania come closer, a vaccine against them does, too

September 13, 2017
Parasites that ulcerate the skin, can disfigure the face, and may fatally mutilate its victim's internal organs are creeping closer to the southern edges of the United States.

Promising clinical trial results could give doctors a new tool against drug-resistant strains of malaria parasite

September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.